Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Georgetown University Medical Center Establishes Center for Drug Discovery

Published: Thursday, October 04, 2012
Last Updated: Thursday, October 04, 2012
Bookmark and Share
University announces the establishment of the Center for Drug Discovery under the inaugural direction of Milton L. Brown, M.D., Ph.D.

The Center for Drug Discovery (CDD) comprises members from various disciplines to collaborate in drug discovery and in the development of a pipeline for molecular targets. The Center will offer a full continuum from drug discovery through pre-clinical studies and clinical trials. In this regard, specialized teams will be formed to bring together medicinal chemists, biologists, scientists and physicians toward a common goal of discovery, and development of new interventions in areas of unmet need in cancer, neurological, cardiovascular and infectious diseases.

“Academic drug discovery is an emerging and much needed area for advancing human health,” explains Brown. “The CDD will help create a model academic center to actively support faculty and collaborators in providing innovative therapies for improving the care of patients.”

Initiatives include education, innovative and transformative research, collaborative programs, and embedded translational expertise, he adds.

The CDD is a translational medicine initiative made possible by the award of a Chemical Diversity Center grant from the National Cancer Institute (NCI) and membership in the NCI Chemical Biology Consortium.

“Georgetown University Medical Center has a long history of distinguished leadership in drug discovery and development,” says Howard J. Federoff, M.D., Ph.D., executive vice president for health sciences at GUMC and executive dean of Georgetown’s School of Medicine. “The CDD will build on these strengths functioning as a vertically integrated research Center within GUMC that will interact with the existing research and clinical capabilities in the discovery and development of novel therapeutics in meeting its goal of multi-disciplinary research and education.”

In addition to serving as the Center’s director, Brown is principal investigator of the NCI Chemical Diversity Center grant. He holds the Edwin H. Richard and Elisabeth Richard von Matsch Endowed Chair in Experimental Therapeutics at Georgetown and is associate professor in the Department of Oncology. A national and international leader in academic drug discovery and development, Brown has filed new patents on novel compounds to treat cancer, epilepsy, pain, chronic kidney disease, hypertension, and radiation sensitizing and protective agents.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

In a Surprise Finding, Gene Mutation Found Linked to Low-Risk Bladder Cancer
The investigators identified STAG2 as one of the most commonly mutated genes in bladder cancer, particularly in tumors that do not spread.
Monday, October 21, 2013
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
JPK NanoWizard® Applied to a Wide Range of Research
The NanoWizard® AFM from JPK is applied for interdisciplinary research at the University of South Australia for applications including smart wound healing and how plants can protect themselves from toxins.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Protein Boosts Rice Yield by 54%
Over-expression of a natural protein in rice plants led to a 54% increase in crop yield and 40% increase in nitrogen-use efficiency.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Genetic Variability in Cell Bank Lots
Researchers working with cancer cells from the same cell bank acquired at the same time, found that the cells were genetically different.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Soil Nitrogen Age Important for Precision Agriculture
Calculating the age of nitrogen in corn and soybean fields could lead to improved fertilizer application techniques.
Targeting Autoimmunity
Researchers have developed a strategy to treat a rare autoimmune disease which could lead to treatments of other autoimmune diseases.
Molecule May Affect Gaucher, Parkinson's Disease
Research has identified a molecule that restores activity of a dysfunctional enzyme linked to Gaucher and Parkinson's disease.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!